会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明专利
    • Application drug for mucosa consisting of multilayer structure
    • MUCOSA包含多层结构的应用药物
    • JPS6130517A
    • 1986-02-12
    • JP14970984
    • 1984-07-20
    • Nichiban Co LtdTaiho Yakuhin Kogyo Kk
    • TAKASUGI MASUMITSUITO TOSHIO
    • A61K9/70
    • PURPOSE: The titled pharmaceutical, having a mucosa adhesive film and an adhesive coated sheet in a laminated structure, capable of controlling the release of a chemical, preventing the swelling of the application drug by water permeated from the outer edge parts, and having improved adhesive property.
      CONSTITUTION: An application drug obtained by applying an adhesive 3, e.g. rubber based adhesive, acrylic adhesive or silicone based adhesive, containing a chemical or no chemical onto a base material 1, e.g. collagen, paper or PE film, and laminating a filmy mucosa adhesive 4, e.g. carboxymethyl cellulose (CMC), hydroxyethyl cellulose or gelatin, containing the chemical or no chemical, to the formed sheet. The adhesive coated sheet part larger than the mucosa adhesive layer is capable of suppressing the swelling of the outer edge parts in application and improving further the adhesive property. A chemical for treating aphtha in the mouth, inhibitor for toothache, remedy for angina pectoris, etc. is used as the chemical, and mainly applied to the mucosa of the oral cavity, pudendum part, etc.
      COPYRIGHT: (C)1986,JPO&Japio
    • 目的:具有粘膜粘膜和层压结构的粘合剂涂层片的标题药物,其能够控制化学品的释放,防止从外缘部渗透的水膨胀施用药物,并且具有改善的粘合剂 属性。 构成:通过施加粘合剂3获得的施用药物,例如 橡胶基粘合剂,丙烯酸粘合剂或硅氧烷基粘合剂,在基材1上含有化学或无化学物质,例如。 胶原蛋白,纸或PE膜,并层压薄膜粘膜4,例如 含有化学或无化学物质的羧甲基纤维素(CMC),羟乙基纤维素或明胶。 大于粘膜粘合剂层的粘合剂涂层片材部分能够在施加时抑制外缘部件的膨胀,并进一步提高粘合性能。 用于治疗口腔中的口腔化学物质,牙痛抑制剂,心绞痛药物等作为化学物质,主要应​​用于口腔粘膜,阴部等。
    • 2. 发明专利
    • Pasting pharmaceutical preparation for remedying disease of circulatory organ
    • 用于补救循环系统疾病的药物制剂
    • JPS6124517A
    • 1986-02-03
    • JP14219284
    • 1984-07-11
    • Nichiban Co Ltd
    • ITO TOSHIO
    • A61K9/70
    • PURPOSE: The titled pharmaceutical preparation having improved irritation to the skin and percutaneous absorption, comprising a pressure-sensitive adhesive consisting of vinyl monomers in a specific ratio, IPM or IPL of percutaneous promotor, and propranolol or pindolol of β-blocking agent, and a tape substrate.
      CONSTITUTION: The titled preparation comprising (A) a tape substrate (PE, PP, etc.), (B) a pressure-sensitive adhesive consisting of (i) 40W99wt% 4W12C alkyl- containing alkyl (meth)acrylate, (ii) 1W50wt% at least one vinyl monomer selected from 1W3C alkyl-containing alkyl (meth)acrylate, vinyl acetate, and styrene, and (iii) 0W10wt% unsaturated carboxylic acid (e.g., acrylic acid, etc.), (C) isopropyl myristate (IPM), or isopropyl laurate (IPL), and (D) propranolol. The titled preparation is a sustained release drug having low side effects, and seldom making patients forget administration (application) thereof.
      COPYRIGHT: (C)1986,JPO&Japio
    • 目的:具有改善对皮肤刺激和经皮吸收的标题药物制剂,其包含由特定比例的乙烯基单体组成的压敏粘合剂,经皮促进剂的IPM或IPL,β-阻断剂的普萘洛尔或吲哚洛尔, 胶带基材。 构成:包含(A)带基材(PE,PP等)的标题制剂,(B)由(i)40-99wt%4-12C烷基(甲基)丙烯酸酯组成的压敏粘合剂, (ii)1-50wt%至少一种选自1-3C烷基(甲基)丙烯酸烷基酯,乙酸乙烯酯和苯乙烯的乙烯基单体,和(iii)0-10wt%不饱和羧酸(例如丙烯酸等) ),(C)肉豆蔻酸异丙酯(IPM)或月桂酸异丙酯(IPL),和(D)普萘洛尔。 标题制剂是副作用低的缓释药物,很少使患者忘记其施用(应用)。
    • 3. 发明专利
    • Mucosa adhesive pharmaceutical
    • MUCOSA胶粘剂药物
    • JPS6130516A
    • 1986-02-12
    • JP14970884
    • 1984-07-20
    • Nichiban Co LtdTaiho Yakuhin Kogyo Kk
    • TAKASUGI MASUMITSUITO TOSHIO
    • A61K9/70A61K47/00A61K47/36
    • PURPOSE: The titled pharmaceutical, having a mucosa-bonding adhesive layer containing an alginic acid ester and a chemical on a base material, and improved adhesive property to mucosa of the oral cavity and good supporting property of the chemical without natural peeling, and excellent for a base of a sustained release mucosa absorption pharmaceutical.
      CONSTITUTION: A mucosa adhesive pharmaceutical obtained by dissolving an ester of alginic acid, preferably a 4W20C higher aliphatic alcohol ester of alginic acid, e.g. n-butyl alginate or n-octyl alginate, and a chemical, e.g. corticosteroid, anesthetic agent or antihistaminic agent, in water, and applying the resultant solution onto a base material. The pharmaceutical is characterized in that the alginic acid ester is used as an adhesive in the mucosa adhesive layer on the base material. The alginic acid ester is an adhesive having improved mucosa bonding property with little swelling deformation by moisture.
      COPYRIGHT: (C)1986,JPO&Japio
    • 目的:具有含有藻酸酯的粘膜粘合剂层和基材上的化学品的标题药物,改善了口腔粘膜的粘合性,并且具有良好的无天然剥离的化学物质的支持性,并且优于 持续释放粘膜吸收药物的基础。 构成:通过将海藻酸的酯优选为海藻酸的4-20℃的高级脂肪醇酯例如溶解而得到的粘膜粘合剂药物。 海藻酸正丁酯或海藻酸正辛酯,以及化学品,例如, 皮质类固醇,麻醉剂或抗组胺剂,并将所得溶液施用到基材上。 该药物的特征在于,将藻酸酯用作基材上的粘膜粘合剂层中的粘合剂。 藻酸酯是具有改善的粘膜粘合性能并且几乎没有水分溶胀变形的粘合剂。